Allotment of 18,33,595 equity shares to non promoter for cash consideration and 300000 Convertible Warrants into Equity shares to promoter and promoter group for cash consideration.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.4 pts less than Nifty Microcap 250 and 1.6 pts less than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Stellant Securities has allotted 18,33,595 equity shares at Rs. 290 per share (face value Rs. 10, premium Rs. 280) to 43 non-promoter allottees, raising approximately Rs. 53.17 crore on a cash basis. Additionally, 3,00,000 convertible warrants were allotted to two promoters — Mangla Subhash Rathod and Subhash Rathod (1.5 lakh each) — at Rs. 340 per warrant, with 25% upfront consideration paid (Rs. 1.27 crore each). The allotments were approved by the Board on February 2, 2026, following shareholder approval at the EGM on December 10, 2025 and BSE in-principle approval on January 19, 2026. The issues were made under Chapter V of SEBI's ICDR Regulations as preferential allotments.
Existing shareholders will face dilution from the new equity shares, with potential further dilution if promoter warrants are later converted into equity. The capital infusion (~Rs. 53 crore in cash plus Rs. 2.55 crore upfront from warrants) strengthens the company's balance sheet, while promoter participation signals confidence, though small investors should note the significant expansion of the share base.